DMII (Drugs Made In America Acquisition II) Short-Term Debt: $0.45 Mil (As of Mar. 2026)


DMII Drugs Made In America Acquisition II Corp DMII
15 GF Score
Price $10.10
! 1 Warning Sign
View Full Analysis

What is Drugs Made In America Acquisition II Short-Term Debt?

Drugs Made In America Acquisition II DMII 15 Short-Term Debt is $0.45 Mil as of Mar. 2026. GuruFocus rates DMII with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

Drugs Made In America Acquisition II's Short-Term Debt for the quarter that ended in Mar. 2026 was $0.45 Mil.

Drugs Made In America Acquisition II's quarterly Short-Term Debt stayed the same from Sep. 2025 ($0.00 Mil) to Dec. 2025 ($0.00 Mil) but then increased from Dec. 2025 ($0.00 Mil) to Mar. 2026 ($0.45 Mil).

Drugs Made In America Acquisition II's annual Short-Term Debt increased from . 20 ($0.00 Mil) to Dec. 2024 ($0.25 Mil) but then declined from Dec. 2024 ($0.25 Mil) to Dec. 2025 ($0.00 Mil).

Drugs Made In America Acquisition II Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Drugs Made In America Acquisition II Short-Term Debt Related Terms

Drugs Made In America Acquisition II Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Drugs Made In America Acquisition II's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drugs Made In America Acquisition II Short-Term Debt Chart

Drugs Made In America Acquisition II Annual Data
Trend Dec24 Dec25
Short-Term Debt
0.25 0.00

Drugs Made In America Acquisition II Quarterly Data
Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial 0.25 0.30 0.00 0.00 0.45
DMII
15GF Score
Drugs Made In America Acquisition II Corp DMII
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0.45 Mil mean?
Drugs Made In America Acquisition II (DMII) has a Short-Term Debt of $0.45 Mil as of Mar. 2026.
Is Drugs Made In America Acquisition II's Short-Term Debt too high?
Drugs Made In America Acquisition II's current Short-Term Debt is $0.45 Mil. Overall, Drugs Made In America Acquisition II has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's Short-Term Debt compare to BCSS and EVAC?
Drugs Made In America Acquisition II's Short-Term Debt of $0.45 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Diversified Financial Services company?
A good Short-Term Debt depends on the Diversified Financial Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Drugs Made In America Acquisition II's current Short-Term Debt is $0.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current Short-Term Debt of $0.45 Mil. The current Short-Term Debt is $0.45 Mil. Drugs Made In America Acquisition II's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current Short-Term Debt is $0.45 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drugs Made In America Acquisition II Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10170
Drugs Made In America Acquisition II Corp is a blank check Company.
15GF Score

Get the complete analysis for DMII

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.10
Price